| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/15/1999 | WO1999000010A3 TRANSGENIC ANIMALS EXPRESSING HUMAN Fc RECEPTORS |
| 04/15/1999 | WO1998058945A9 Compounds encoding the protective m-like protein of streptococcus equi and assays therefor |
| 04/15/1999 | WO1998058668A3 Bordetella pertussis antigens as carriers in vaccinating conjugates and oral vaccines comprising bordetella pertussis fimbriae |
| 04/15/1999 | WO1998053799A3 Immunogenic compositions |
| 04/15/1999 | WO1998052582A8 Non-myeloablative tolerogenic treatment |
| 04/15/1999 | WO1998048022A9 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 04/15/1999 | WO1998046645A3 Method for the production of antihuman antigen receptors and uses thereof |
| 04/15/1999 | DE19821506A1 Associate of cdc37 protein and extracellular nucleic acid as marker for transformed cells, used for detection and removal of these cells |
| 04/15/1999 | DE19744127A1 Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with Cyclopropylringen in the side chains, processes and intermediates for their preparation and their use for the production of pharmaceuticals |
| 04/15/1999 | CA2308126A1 Modulation of lerk-2-mediated cell adhesion |
| 04/15/1999 | CA2308123A1 Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions |
| 04/15/1999 | CA2306452A1 Use of growth differentiation factor-9 (gdf-9) as a contraceptive |
| 04/15/1999 | CA2306182A1 Gene deleted recombinant felv proviral dna for production of vaccines against felv |
| 04/15/1999 | CA2305785A1 Method for introducing and expressing rna in animal cells |
| 04/15/1999 | CA2305709A1 Chlamydia protein, gene sequence and uses thereof |
| 04/15/1999 | CA2305688A1 Methods and compositions for treating rheumatoid arthritis |
| 04/15/1999 | CA2305620A1 Method for the covalent attachment of polysaccharides to protein molecules |
| 04/15/1999 | CA2305599A1 Imine-forming polysaccharides, preparation thereof and the use thereof as adjuvants and immunostimulants |
| 04/15/1999 | CA2305528A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 04/15/1999 | CA2305382A1 Papilloma virus capsomere vaccine formulations and methods of use |
| 04/15/1999 | CA2305182A1 Methods and compositions for the selective modification of nucleic acids |
| 04/15/1999 | CA2304803A1 Protein delivery by secretory gland expression |
| 04/15/1999 | CA2304354A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/15/1999 | CA2304350A1 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 04/14/1999 | EP0908519A1 Novel glucosaminidase from Staphylococcus aureus |
| 04/14/1999 | EP0908518A2 MurE gene encoding uridine-diphosphate-N-acetylmuramoyl-L-alanyl-D-glutamate:L-lysine ligase of Streptococcus pneumoniae |
| 04/14/1999 | EP0908517A2 Viral vaccines |
| 04/14/1999 | EP0908514A1 LicD1 polyperides from Streptococcus pneumoniae |
| 04/14/1999 | EP0907746A2 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 04/14/1999 | EP0907742A2 Cyclic nucleotide phosphodiesterase |
| 04/14/1999 | EP0907740A1 THE PROCESS FOR EXPRESSION AND PRODUCTION OF RECOMBINANT PROTEIN HYBRID PROTEIN (p24/p17) DERIVED FROM HUMAN IMMUNODEFICIENCY VIRUSES (HIV-1) |
| 04/14/1999 | EP0907739A1 Porcine retrovirus |
| 04/14/1999 | EP0907738A1 Novel compounds |
| 04/14/1999 | EP0907735A1 Modulators of tissue regeneration |
| 04/14/1999 | EP0907733A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 04/14/1999 | EP0907720A1 Combined radiotherapy and immunotherapy to treat cancer |
| 04/14/1999 | EP0907661A1 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF alpha v beta 5 MEDIATED ANGIOGENESIS |
| 04/14/1999 | EP0907378A1 Concentrated antibody preparation |
| 04/14/1999 | EP0907377A1 Novel compounds |
| 04/14/1999 | EP0907376A1 Novel compounds |
| 04/14/1999 | EP0907375A1 Novel compounds |
| 04/14/1999 | EP0907370A1 Hla-a2.1 binding peptides and their uses |
| 04/14/1999 | EP0907369A1 Materials and methods for treatment of plaquing diseases |
| 04/14/1999 | EP0777685B1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 04/14/1999 | EP0734436B1 Inhibition of dna methyltransferase |
| 04/14/1999 | EP0643559B1 Diphtheria toxin receptor-binding region |
| 04/14/1999 | EP0618814B1 Recombinant bovine herpesvirus type 1 polypeptides and vaccines |
| 04/14/1999 | EP0548200B1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 04/14/1999 | CN1214083A Mixture of recominant vaccinia vectors as polyenv vaccines for HIV |
| 04/14/1999 | CN1214080A Glycorprotein B of RFHV/KSHV subfamily of herpes viruses |
| 04/14/1999 | CN1214051A Induction of immune responese against desired determinants |
| 04/13/1999 | US5894018 Vaccine composition comprising autologous epidermal growth factor or a fragment or a derivative thereof having anti-tumor activity and use thereof in the therapy of malignant diseases |
| 04/13/1999 | CA2064046C Method of isolating restriction fragment deletions in vibrio cholerae, and products thereof |
| 04/13/1999 | CA2037311C Method of inhibiting fungi |
| 04/13/1999 | CA1340494C Induction of tolerance to a foreign antigen |
| 04/13/1999 | CA1340491C Interleukin-7 |
| 04/10/1999 | CA2246632A1 Novel mure |
| 04/10/1999 | CA2225180A1 Non-mammalian mesoderm induction early response (mier) gene family |
| 04/10/1999 | CA2212991A1 Invertebrate mesoderm induction early response (mier) gene family |
| 04/09/1999 | CA2246635A1 Novel glucosaminidase |
| 04/08/1999 | WO1999016892A1 Bovine herpesvirus 2 (bhv-2) based vector and its uses |
| 04/08/1999 | WO1999016888A2 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 04/08/1999 | WO1999016884A1 Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 04/08/1999 | WO1999016882A1 LMB GENE OF $i(STREPTOCOCCUS AGALACTIAE) |
| 04/08/1999 | WO1999016881A1 Antigen protein and nucleic acid coding for said protein |
| 04/08/1999 | WO1999016874A1 Nucleic acids coding for proteins capable of interacting with presenilins |
| 04/08/1999 | WO1999016864A1 Stimulation of hematopoietic cells in vitro |
| 04/08/1999 | WO1999016789A1 Apoptosis-related compounds and their use |
| 04/08/1999 | WO1999016745A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 04/08/1999 | WO1999016710A1 Immunogenic conjugated polypeptide for treatment of herpes simplex virus |
| 04/08/1999 | WO1999016468A1 Antigen vectors in the form of multilamellar vesicles |
| 04/08/1999 | WO1999016467A1 Non-anaphylactic forms of allergens and their use |
| 04/08/1999 | WO1999016466A2 Vaccine compositions and methods of enhancing vaccine efficacy |
| 04/08/1999 | WO1999016455A1 Mannose receptor bearing cell line and antigen composition |
| 04/08/1999 | WO1999016427A1 Active agent transport systems |
| 04/08/1999 | WO1999016426A2 Multilamellar coalescence vesicles (mlcv) containing biologically active compounds |
| 04/08/1999 | WO1999016417A1 Buccal, polar and non-polar spray or capsule |
| 04/08/1999 | WO1999003987A3 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 04/08/1999 | WO1999002695A3 Epitopes and active sites of paramyxoviridae proteins and uses thereof |
| 04/08/1999 | WO1998057993A9 Secretory immunoglobulin produced by single cells and methods for making and using same |
| 04/08/1999 | WO1998056919A9 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 04/08/1999 | WO1998056913A9 Smad6 and uses thereof |
| 04/08/1999 | WO1998055618A9 Mitofusin genes and their uses |
| 04/08/1999 | WO1998055154A9 Radioprotectant for peptides labeled with radioisotope |
| 04/08/1999 | WO1998049314A8 ANTIGENIC COMPOSITION AND METHOD OF DETECTION FOR $i(HELICOBACTER PYLORI) |
| 04/08/1999 | WO1998035694A9 A pharmaceutical composition for treating hepatitis b virus (hbv) infection |
| 04/08/1999 | WO1998009990A8 Fungal antigens and process for producing the same |
| 04/08/1999 | CA2305781A1 Nucleic acids coding for proteins capable of interacting with presenilins |
| 04/08/1999 | CA2305686A1 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 04/08/1999 | CA2305681A1 Apoptosis-related compounds and their use |
| 04/08/1999 | CA2305625A1 Altered dna synthesome components as biomarkers for malignancy |
| 04/08/1999 | CA2305140A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 04/08/1999 | CA2304951A1 Active agent transport systems |
| 04/08/1999 | CA2304824A1 Antigen vectors in the form of multilamellar vesicles and compositions containing antigens encapsulated in these vesicles |
| 04/08/1999 | CA2304665A1 Immunogenic conjugated polypeptide for treatment of herpes simplex virus |
| 04/08/1999 | CA2304206A1 Stimulation of hematopoietic cells in vitro |
| 04/08/1999 | CA2246626A1 Rabies recombinant adenovirus |
| 04/08/1999 | CA2245937A1 Novel histidine kinase |
| 04/08/1999 | CA2245924A1 A method of identifying agonists and antagonists for tumor necrosis related receptors tr1, tr3 and tr5 |
| 04/08/1999 | CA2212606A1 A target for pre-symptomatic detection, control and prevention of multiple sclerosis in humans |